Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Clinical & Experimental Metastasis
Published in: Clinical & Experimental Metastasis 2/2002

01-03-2002

Cumulative influence of elastin peptides and plasminogen on matrix metalloproteinase activation and type I collagen invasion by HT-1080 fibrosarcoma cells

Authors: Eric Huet, Bertrand Brassart, Jean-Hubert Cauchard, Laurent Debelle, Philippe Birembaut, Jean Wallach, Herve Emonard, Myriam Polette, William Hornebeck

Published in: Clinical & Experimental Metastasis | Issue 2/2002

Login to get access
Metadata
Title
Cumulative influence of elastin peptides and plasminogen on matrix metalloproteinase activation and type I collagen invasion by HT-1080 fibrosarcoma cells
Authors
Eric Huet
Bertrand Brassart
Jean-Hubert Cauchard
Laurent Debelle
Philippe Birembaut
Jean Wallach
Herve Emonard
Myriam Polette
William Hornebeck
Publication date
01-03-2002
Publisher
Kluwer Academic Publishers
Published in
Clinical & Experimental Metastasis / Issue 2/2002
Print ISSN: 0262-0898
Electronic ISSN: 1573-7276
DOI
https://doi.org/10.1023/A:1014547324918

Other articles of this Issue 2/2002

Clinical & Experimental Metastasis 2/2002 Go to the issue

OriginalPaper

Resistance to apoptosis is increased during metastatic dissemination of colon cancer

OriginalPaper

Distinctive alterations of invasiveness, drug resistance and cell–cell organization in 3D-cultures of MCF-7, a human breast cancer cell line, and its multidrug resistant variant

OriginalPaper

Morphometric analysis of liver macrophages in patients with colorectal liver metastasis

OriginalPaper

Inhibition of endogenous carcinoembryonic antigen (CEA) increases the apoptotic rate of colon cancer cells and inhibits metastatic tumor growth

OriginalPaper

Regulation of melanoma cell migration and invasion by laminin-5 and α3β1 integrin (VLA-3)

OriginalPaper

Interleukin-8 and vascular endothelial growth factor mRNA and protein levels are down-regulated in ovarian carcinoma cells in serous effusions
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits